Bay Colony Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,150
Closed -$205K 344
2022
Q4
$205K Buy
+4,150
New +$170K 0.05% 325
2020
Q1
Sell
-4,500
Closed -$427K 193
2019
Q4
$427K Sell
4,500
-900
-17% -$79.1K 0.28% 129
2019
Q3
$488K Buy
+5,400
New +$615K 0.33% 107

Other funds holding EXAS

Bay Colony Advisors's EXAS Position: Q1 2023 in Review

Bay Colony Advisors sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 4,150 shares — an estimated $205K sold.

Bay Colony Advisors first reported a position in EXAS in Q3 2019 and held it in 3 quarters. The position peaked at $488K in Q3 2019. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Bay Colony Advisors reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Bay Colony Advisors sold 4,150 Exact Sciences shares in Q1 2023, an estimated $205K.
  • Bay Colony Advisors first reported a position in Exact Sciences in Q3 2019 and held it in 3 quarters.
  • Bay Colony Advisors's Exact Sciences position peaked at $488K in Q3 2019.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Bay Colony Advisors's 13F filing for Q1 2023, filed 27 Apr 2023.